DEM
PMN icon

Disciplined Equity Management’s ProMIS Neurosciences PMN Stock Holding History

Disciplined Equity Management’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$441 – 57
2025
Q4 		$441 Buy
+1,000
New +$9.75K ﹤0.01% 62

Other funds holding PMN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM

Disciplined Equity Management's PMN Position: Q1 2026 in Review

Disciplined Equity Management sold out of ProMIS Neurosciences (PMN) in Q1 2026, closing a stake of 1,000 shares — an estimated $441 sold.

Disciplined Equity Management first reported a position in PMN in Q4 2025 and held it in 1 quarter. The position peaked at $441 in Q4 2025. 25 funds tracked by Wall St. Rank hold PMN as of Q1 2026.

  • Disciplined Equity Management reported no remaining ProMIS Neurosciences position as of Q1 2026 after selling out during the quarter.
  • Disciplined Equity Management sold 1,000 ProMIS Neurosciences shares in Q1 2026, an estimated $441.
  • Disciplined Equity Management first reported a position in ProMIS Neurosciences in Q4 2025 and held it in 1 quarter.
  • Disciplined Equity Management's ProMIS Neurosciences position peaked at $441 in Q4 2025.
  • 25 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q1 2026.

Based on Disciplined Equity Management's 13F filing for Q1 2026, filed 28 Apr 2026.